收藏商品
全国免费服务热线
4000-520-616
ATPcitratelyase(ACL)inhibitor(IC50=0.13μMforhumanrecombinantACL);blockslipidsynthesis(IC50=8μMinHepG2cells).Displaysnocytotoxicityuptoaconcentrationof50μM.Lowersplasmaglucoseandtriglyceridesinamousemodelofhyperlipidemia.Orallybioavailable.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight424.3.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Lietal(2007)2-hydroxy-N-arylbenzenesulfonamidesasATP-citratelyaseinhibitors.Bioorg.Med.Chem.Lett.173208PMID:17383874
Maetal(2009)AnoveldirecthomogeneousassayforATPcitratelyase.J.LipidRes.502131PMID:19286649
Keywords:BMS303141,supplier,BMS303141,ATP,citrate,lyases,inhibits,inhibitors,plasma,glucose,triglycerides,orally,bioavailable,synthases,transferases,ACLY,ATP,Citrate,Lyase,ATP,Citrate,Lyase,TocrisBioscience
极简而严谨,我们仅销售188款生物医学科研用品,款款都是爆款;因为少所以聚焦,聚焦甄选每一款产品,聚焦服务每一位客户!
关注我们 :
品质甄选,正品保证
自营电商,厂家直采
极简主义,188精品
公司版权所有 © 2005-2021 苏州蚂蚁淘生物科技有限公司 苏ICP备17049038号-10